Aemetis Inc has a consensus price target of $13.17 based on the ratings of 6 analysts. The high is $28 issued by HC Wainwright & Co. on May 10, 2024. The low is $3 issued by Piper Sandler on June 6, 2023. The 3 most-recent analyst ratings were released by Truist Securities, HC Wainwright & Co., and HC Wainwright & Co. on May 13, 2024, May 10, 2024, and March 8, 2024, respectively. With an average price target of $20 between Truist Securities, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 452.49% upside for Aemetis Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/13/2024 | Buy Now | 10.5% | Truist Securities | Jordan Levy | $3.5 → $4 | Reiterates | Hold → Hold | Get Alert |
05/10/2024 | Buy Now | 673.48% | HC Wainwright & Co. | Amit Dayal | → $28 | Reiterates | Buy → Buy | Get Alert |
03/08/2024 | Buy Now | 673.48% | HC Wainwright & Co. | Amit Dayal | → $28 | Reiterates | Buy → Buy | Get Alert |
02/21/2024 | Buy Now | 79.56% | Stifel | Derrick Whitfield | $8 → $6.5 | Maintains | Buy | Get Alert |
01/23/2024 | Buy Now | 120.99% | Stifel | Derrick Whitfield | $7.5 → $8 | Maintains | Buy | Get Alert |
01/23/2024 | Buy Now | -3.31% | Truist Securities | Jordan Levy | $5 → $3.5 | Maintains | Hold | Get Alert |
11/27/2023 | Buy Now | 107.18% | Stifel | Derrick Whitfield | $10 → $7.5 | Maintains | Buy | Get Alert |
09/15/2023 | Buy Now | 673.48% | HC Wainwright & Co. | Amit Dayal | → $28 | Reiterates | Buy → Buy | Get Alert |
08/22/2023 | Buy Now | 190.06% | Stifel | Derrick Whitfield | $9 → $10.5 | Maintains | Buy | Get Alert |
08/16/2023 | Buy Now | 190.06% | UBS | Manav Gupta | $2.5 → $10.5 | Upgrade | Neutral → Buy | Get Alert |
08/04/2023 | Buy Now | 673.48% | HC Wainwright & Co. | Amit Dayal | → $28 | Reiterates | Buy → Buy | Get Alert |
07/07/2023 | Buy Now | 162.43% | Stifel | Derrick Whitfield | $9 → $9.5 | Maintains | Buy | Get Alert |
06/06/2023 | Buy Now | -17.13% | Piper Sandler | Ryan Todd | $2 → $3 | Maintains | Underweight | Get Alert |
04/27/2023 | Buy Now | 148.62% | Stifel | Derrick Whitfield | $10 → $9 | Maintains | Buy | Get Alert |
04/14/2023 | Buy Now | 176.24% | Stifel | Derrick Whitfield | $18 → $10 | Maintains | Buy | Get Alert |
04/13/2023 | Buy Now | -30.94% | Truist Securities | Jordan Levy | $5 → $2.5 | Maintains | Hold | Get Alert |
02/28/2023 | Buy Now | -17.13% | Piper Sandler | Ryan Todd | → $3 | Initiates | → Underweight | Get Alert |
02/01/2023 | Buy Now | 38.12% | Truist Securities | Jordan Levy | $9 → $5 | Maintains | Hold | Get Alert |
12/14/2022 | Buy Now | 17.4% | UBS | Manav Gupta | → $4.25 | Initiates | → Neutral | Get Alert |
08/09/2022 | Buy Now | 231.49% | Truist Securities | Jordan Levy | → $12 | Downgrade | Buy → Hold | Get Alert |
06/13/2022 | Buy Now | 645.86% | Credit Suisse | Manav Gupta | $35 → $27 | Maintains | Outperform | Get Alert |
08/23/2021 | Buy Now | 756.35% | Credit Suisse | Manav Gupta | — | Maintains | Outperform | Get Alert |
The latest price target for Aemetis (NASDAQ:AMTX) was reported by Truist Securities on May 13, 2024. The analyst firm set a price target for $4.00 expecting AMTX to rise to within 12 months (a possible 10.50% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for Aemetis (NASDAQ:AMTX) was provided by Truist Securities, and Aemetis reiterated their hold rating.
The last upgrade for Aemetis Inc happened on August 16, 2023 when UBS raised their price target to $10.5. UBS previously had a neutral for Aemetis Inc.
The last downgrade for Aemetis Inc happened on August 9, 2022 when Truist Securities changed their price target from N/A to $12 for Aemetis Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aemetis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aemetis was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.
While ratings are subjective and will change, the latest Aemetis (AMTX) rating was a reiterated with a price target of $3.50 to $4.00. The current price Aemetis (AMTX) is trading at is $3.62, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.